You did not establish and maintain procedures for testing, screening and determining the eligibility of HCT/P donors.
Inspection Record
Conceive Fertility Center — FDA 483 Findings
Inspectors Ramon L Gonzalez-PrietoThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
After the completion of the donor-eligibility determination, HCT/Ps were not accompanied with a statement whether the donor has been determined to be eligible or ineligible, based on the results of screening and testing.
Information on of donors of HCT/Ps were not in English and not accompanied by a statement of authenticity by the translator that specifically identifies the translated document.
A standard operating procedure for the release of HCT/Ps from donors that test reactive for cytomegalovirus (CMV) was not established, defined, documented and implemented.
The eligibility of an HCT/P donor was not determined and documented by a responsible person, based on results of donor screening and donor testing.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.